Press release
Rising Cancer Incidence Fuels Growth Of The Market: A Key Factor Shaping the Future of the Omisirge Market in 2025
Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!What industry-specific factors are fueling the growth of the omisirge market?
The increasing prevalence of cancer is expected to drive the growth of the omisirge market. Cancer is characterized by uncontrolled cell growth that can invade surrounding tissues and spread to other parts of the body. The rise in cancer cases is largely driven by factors such as increased exposure to carcinogens (e.g., tobacco, UV radiation, and chemicals), a growing elderly population, and lifestyle factors like diet and exercise. Omisirge offers an innovative approach to cancer treatment by targeting the immune system to enhance its natural ability to fight cancer cells, providing a promising therapeutic option for cancers that are resistant to traditional therapies. For example, in January 2023, the American Cancer Society reported that the number of cancer cases had increased to 1,958,310 in 2023, a growth of 3.16% from 1,898,160 in 2021. This surge in cancer cases is contributing to the growing demand for omisirge.
Get Your Omisirge Market Report Here:
https://www.thebusinessresearchcompany.com/report/omisirge-global-market-report
What Is the projected market size and growth rate for the omisirge market?
The omisirge market size has grown at XX (HCAGR) in recent years. It is expected to increase from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. Factors driving this growth include the prevalence of chronic disorders, an increase in clinical trials, a rising geriatric population, improving healthcare infrastructure, and expanding research and development activities.
The Omisirge market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing healthcare expenditure, rising government initiatives, rising disposable income, increasing personalized medicines, and growing prevalence of cancer. Major trends in the forecast period include a focus on product launch, strategic collaboration, technological advancement, drug approval by authorities, and investment in research and development.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20269&type=smp
What new trends are reshaping the omisirge market and its opportunities?
One key development in the omisirge market is the attainment of drug authorization from regulating bodies to secure a competitive advantage in the sector. Drug authorization encompasses the assessment and approval of a new drug for usage and sale by regulatory bodies, ensuring its safety, efficacy, and quality based on data from clinical trials. For instance, in April 2023, the U.S. Food and Drug Administration gave its approval to Gamida Cell Ltd., a biotechnology company based in the US, for the usage of Omisirge in adult and pediatric patients aged 12 and above suffering from hematologic malignancies who undergo umbilical cord blood transplantation after myeloablative conditioning. This approval signals a significant step forward in cell therapy for patients with blood cancer, as Omisirge is engineered to speed up neutrophil recovery and decrease the risk of infection. Administered in a single intravenous dose, Omisirge is made up of human allogeneic stem cells grown with nicotinamide (a type of vitamin B3). Each dose for the patients is prepared using healthy stem cells from a carefully picked unrelated donor, instead of the patient's own cells.
What major market segments define the scope and growth of the omisirge market?
The omisirge market covered in this report is segmented -
1) By Clinical Indication: Leukemia; Lymphoma; Myeloma; Other Hematologic Malignancies
2) By Distribution Channel: Direct Sales; Distributors
3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20269
Which region dominates the omisirge market?
North America was the largest region in the omisirge market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omisirge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the omisirge industry growth?
Major companies operating in the omisirge market are Gamida Cell Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20269&type=smp
What Is Covered In The Omisirge Global Market Report?
•Market Size Forecast: Examine the omisirge market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the omisirge market for a structured understanding.
•Key Players Overview: Analyze major players in the omisirge market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the omisirge market.
•Segment Contributions: Evaluate how different segments drive overall growth in the omisirge market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the omisirge market.
•Industry Challenges: Identify potential risks and obstacles affecting the omisirge market.
•Competitive Landscape: Review strategic developments in the omisirge market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cancer Incidence Fuels Growth Of The Market: A Key Factor Shaping the Future of the Omisirge Market in 2025 here
News-ID: 3943509 • Views: …
More Releases from The Business research company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…

Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…

Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…

Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Omisirge
Impact Of Rising Chronic Diseases On The Growth Of The Market : An Emerging Driv …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Omisirge Market?
In recent years, the market size of omisirge has seen an XX (HCAGR) growth. The market, valued at $XX million in 2024, is projected to see an increase to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. This…
Aplastic Anemia Treatment Market Size in the 7MM was ~USD 270 million in 2023 an …
DelveInsight's "Aplastic Anemia Treatment Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Aplastic Anemia, historical and forecasted epidemiology, as well as the Aplastic Anemia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover which therapies are expected to grab the Aplastic Anemia Market Share @ Aplastic Anemia Market Outlook [https://www.delveinsight.com/sample-request/aplastic-anemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Aplastic Anemia…
Aplastic Anemia Treatment Market Size in 7MM is expected to grow at a decent CAG …
DelveInsight's " Aplastic Anemia Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth understanding of the Aplastic Anemia, historical and forecasted epidemiology as well as the Aplastic Anemia Market Trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Unlock key insights into the Aplastic Anemia Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Aplastic Anemia Therapeutics…
Transforming the Omisirge Market in 2025: Rising Cancer Incidence Fuels Growth O …
What Is the Expected Size and Growth Rate of the Omisirge Market?
The scale of the omisirge market has surged by $XX (CAGR) in the past few years. It's projected to expand from a worth of $XX million in 2024 to a projected $XX million in 2025, at a compound annual growth rate (CAGR) of $XX%. This escalating growth witnessed during the historic period is linked to factors such as the…
Aplastic Anemia Treatment Market Size, Emerging Drugs, Market Outlook, and Compa …
DelveInsight's "Aplastic Anemia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the aplastic anemia, historical and forecasted epidemiology as well as the aplastic anemia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Unlock detailed insights into the Aplastic Anemia Market by downloading the comprehensive report from DelveInsight @ Aplastic Anemia Therapeutics Market- https://www.delveinsight.com/sample-request/aplastic-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways…
Aplastic Anemia Market Size is Set for Rapid Growth as Innovative Treatments and …
The market size of Aplastic Anemia is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Pfizer, BioLineRx Ltd., Regeneron Pharmaceuticals, Gamida Cell, Elixirgen, Hangzhou Zede Pharmaceutical Technology, Cellenkos, Hemogenyx Pharmaceuticals.
[Nevada, United States] - DelveInsight's "Aplastic Anemia Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Aplastic Anemia, covering historical and predicted…